Literature DB >> 16153756

Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response.

William T Golde1, Juan M Pacheco, Hernando Duque, Timothy Doel, Barry Penfold, Geoffrey S Ferman, Douglas R Gregg, Luis L Rodriguez.   

Abstract

Recent outbreaks of foot-and-mouth disease virus (FMDV) demonstrate that this highly contagious viral infection of cloven hoofed animals continues to be a significant economic problem worldwide. Debate about the most effective way to respond to outbreaks of FMDV in disease free countries continues to center on the use of vaccines. In this report, we present data showing that a commercially available, standard dose vaccine formulation can fully protect cattle against direct challenge with the virus in as little as 7 days with no carrier transmission to naïve animals. Cattle challenged 4 days after vaccination have reduced disease severity, no detectable virus in blood and little virus shedding from nasal secretions. These significant effects at 4 days post vaccination, confirmed in two separate trials, support the value of using currently available vaccines as a first line of defense against foot-and-mouth disease (FMD) outbreaks.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16153756     DOI: 10.1016/j.vaccine.2005.07.043

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  52 in total

1.  Modeling the spread and control of foot-and-mouth disease in Pennsylvania following its discovery and options for control.

Authors:  Michael J Tildesley; Gary Smith; Matt J Keeling
Journal:  Prev Vet Med       Date:  2011-12-12       Impact factor: 2.670

2.  Accessory-cell-mediated activation of porcine NK cells by toll-like receptor 7 (TLR7) and TLR8 agonists.

Authors:  Felix N Toka; Charles K Nfon; Harry Dawson; William T Golde
Journal:  Clin Vaccine Immunol       Date:  2009-04-15

3.  Protection against direct in-contact challenge following foot-and-mouth disease vaccination in sheep and goats: the effect on virus excretion and carrier status.

Authors:  Muthukrishnan Madhanmohan; Singanallur Balasubramanian Nagendrakumar; Villuppanoor Alwar Srinivasan
Journal:  Vet Res Commun       Date:  2010-03-30       Impact factor: 2.459

4.  Robust Protection against Highly Virulent Foot-and-Mouth Disease Virus in Swine by Combination Treatment with Recombinant Adenoviruses Expressing Porcine Alpha and Gamma Interferons and Multiple Small Interfering RNAs.

Authors:  Su-Mi Kim; Jong-Hyeon Park; Kwang-Nyeong Lee; Se-Kyung Kim; Su-Hwa You; Taeseong Kim; Dongseob Tark; Hyang-Sim Lee; Min-Goo Seo; Byounghan Kim
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

5.  Immune potential of a novel multiple-epitope vaccine to FMDV type Asia 1 in guinea pigs and sheep.

Authors:  Jun-jun Shao; Jing-feng Wang; Hui-yun Chang; Ji-xing Liu
Journal:  Virol Sin       Date:  2011-06-12       Impact factor: 4.327

6.  Seroprevalence of foot-and-mouth disease in the southern provinces of Cambodia.

Authors:  Sothyra Tum; Ian Ducan Robertson; John Edwards; Ronello Abila; Subhash Morzaria
Journal:  Trop Anim Health Prod       Date:  2015-01-24       Impact factor: 1.559

7.  Interferon-induced protection against foot-and-mouth disease virus infection correlates with enhanced tissue-specific innate immune cell infiltration and interferon-stimulated gene expression.

Authors:  Fayna Diaz-San Segundo; Mauro P Moraes; Teresa de Los Santos; Camila C A Dias; Marvin J Grubman
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

8.  Serological survey for foot-and-mouth disease virus in wildlife in eastern Africa and estimation of test parameters of a nonstructural protein enzyme-linked immunosorbent assay for buffalo.

Authors:  B M D C Bronsvoort; S Parida; I Handel; S McFarland; L Fleming; P Hamblin; R Kock
Journal:  Clin Vaccine Immunol       Date:  2008-04-02

9.  Expression of porcine fusion protein IRF7/3(5D) efficiently controls foot-and-mouth disease virus replication.

Authors:  Lisbeth Ramírez-Carvajal; Fayna Díaz-San Segundo; Danielle Hickman; Charles R Long; James Zhu; Luis L Rodríguez; Teresa de los Santos
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

10.  A safe foot-and-mouth disease vaccine platform with two negative markers for differentiating infected from vaccinated animals.

Authors:  Sabena Uddowla; Jason Hollister; Juan M Pacheco; Luis L Rodriguez; Elizabeth Rieder
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.